+14,028.3%
EBAY vs GSK
+175.7%
+13,852.5%
-82.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | +0.2% | -1.2% | -1.1% |
| 7D | -3.0% | -3.6% | +0.6% | -1.6% |
| 30D | -3.6% | -5.9% | +2.3% | -1.4% |
| 3M | -4.4% | -4.3% | -0.2% | -3.0% |
| 6M | +12.1% | -10.8% | +22.9% | +16.5% |
| YTD | +19.9% | +1.8% | +18.1% | +17.4% |
| 1Y | +13.4% | +23.5% | -10.1% | +1.7% |
| 3Y | +150.5% | +49.5% | +100.9% | +102.2% |
| 5Y | +54.8% | +49.7% | +5.2% | +21.9% |
| 10Y | +268.1% | +81.9% | +186.1% | +157.6% |
| All | +14,028.3% | +175.7% | +13,852.5% | +7,486.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling